How much is Cartography Biosciences worth in 2026?

Cartography Biosciences has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Cartography Biosciences raised?

Cartography Biosciences has raised $143.0M in total funding across 1 funding rounds.

Cartography Biosciences

Website

Cartography Biosciences valuation and funding history | Last updated: May 22, 2025 | 1 funding rounds

Current Valuation

N/A

As of May 22, 2025

Total Funding Raised

$143.0M

Across 1 round

Last Round

Later Stage VC

$80.0M

Last Funding

May 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Cartography Biosciences is currently valued at N/A as of May 22, 2025. The company has raised a total of $143.0M in funding across 1 funding round.

Track Cartography Biosciences Valuation Updates

Get notified when Cartography Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Cartography Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Cartography Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Cartography Biosciences Worth in 2026?

Cartography Biosciences is a leading private company in the technology sector. Track Cartography Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Cartography Biosciences Valuation is Determined

Private company valuations like Cartography Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.